RBM15 and breast cancer: Activation of the core reactive pathway, comprised of stromal proteins, Claudin7, E-cadherin, Beta-catenin, RBM15 and Caveolin1, was first discovered as associated with poor survival in breast cancers {Ha, 2018 #345}.